A philanthropic organization is obligated to rescind financial support from any research consortium that reallocates primary grant funds toward unapproved speculative methodologies, unless the consortium has already published peer-reviewed breakthroughs. However, financial support must under no circumstances be rescinded if such an action would irreparably compromise vital longitudinal clinical trials, provided that the investigators transparently disclosed all financial reallocations to an independent oversight committee.
Which one of the following scenarios most closely conforms to the principle stated above?
- The Zenith Foundation's grantee, an oncology consortium, reallocated primary grant funds to unapproved speculative methodologies and has yet to publish any peer-reviewed breakthroughs. Although rescinding support would irreparably compromise vital longitudinal clinical trials, the investigators deliberately concealed their reallocations from the independent oversight committee. Therefore, the Foundation is obligated to rescind financial support.Cevap
- BThe Meridian Foundation's grantee did not reallocate any primary grant funds toward unapproved speculative methodologies, and it has already published multiple peer-reviewed breakthroughs. Consequently, the Foundation must under no circumstances rescind financial support, even though the consortium's work involves no longitudinal clinical trials.
- CThe Aegis Foundation's grantee reallocated funds to unapproved speculative methodologies but transparently disclosed these reallocations to the independent oversight committee. Therefore, the Foundation must not rescind financial support, even if rescinding the support would not irreparably compromise any vital longitudinal clinical trials.
- DThe Lumina Foundation's grantee published several peer-reviewed breakthroughs but failed to transparently disclose its financial reallocations to the independent oversight committee. Because the investigators lacked transparency, the Foundation is obligated to rescind financial support.
- EThe Vertex Foundation's grantee reallocated funds to unapproved methodologies without yielding breakthroughs. The investigators transparently disclosed this reallocation, and rescinding the support might possibly compromise some longitudinal clinical trials. Therefore, the Foundation must under no circumstances rescind financial support.
Cevap
The scenario describing the Zenith Foundation correctly applies the principle. Since the grantee reallocated funds without breakthroughs, the obligation to rescind is triggered. The exception protecting the grant does not apply because the investigators concealed the reallocations, failing the necessary condition of transparency.
The correct answer accurately synthesizes both layers of the principle. The initial condition for mandatory rescission is satisfied because the oncology consortium reallocated funds without having published breakthroughs. Next, we must check if the override condition (which forbids rescission) is triggered. Although the trials would be compromised, the investigators failed the necessary condition of transparent disclosure by concealing their actions. Because the exception is blocked, the original obligation to rescind remains perfectly valid.
Adım Adım Çözüm
Anahtar Kavram
Complex Conditional Logic and Principle Application